Eli Lilly and Company (LLY)

Receivables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	45,042,700	40,863,300	38,922,800	35,932,100	34,124,100	32,072,500	29,515,500	27,691,400	28,541,400	29,239,500	29,070,700	29,322,800	28,318,400	27,758,500	26,726,300	25,485,600	24,539,800	23,213,800	22,949,800	23,087,100
Receivables	US$ in thousands	13,275,400	12,051,700	13,079,000	10,013,500	11,336,200	10,363,800	9,171,400	9,022,100	6,896,000	8,324,800	7,672,400	7,805,700	6,672,800	7,025,000	6,902,800	6,658,600	5,875,300	5,844,800	5,775,600	6,352,500
Receivables turnover		3.39	3.39	2.98	3.59	3.01	3.09	3.22	3.07	4.14	3.51	3.79	3.76	4.24	3.95	3.87	3.83	4.18	3.97	3.97	3.63

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $45,042,700K ÷ $13,275,400K
= 3.39

The receivables turnover ratio of Eli Lilly and Company has fluctuated over the reporting periods provided. The ratio indicates how efficiently the company is collecting outstanding receivables from customers. A higher turnover ratio suggests that the company is collecting receivables more quickly.

From March 31, 2020, to December 31, 2024, the receivables turnover ratio ranged from 2.98 to 4.24. The highest turnover ratio was recorded on December 31, 2021, at 4.24, suggesting a strong ability to collect receivables efficiently during that period. Conversely, the lowest turnover ratio of 2.98 was observed on June 30, 2024.

Overall, the trend in receivables turnover ratios for Eli Lilly and Company indicates some volatility, with fluctuations in the company's ability to collect receivables efficiently over the reporting periods. It would be essential for analysts to further investigate the reasons behind these fluctuations to assess the company's management of receivables effectively.